Gene patents overturned in landmark US Supreme Court decision

Parliament house flag post

Gene patents overturned in landmark US Supreme Court decision

Posted 17/06/2013 by Genevieve Butler

The landmark decision of the US Supreme Court in the Association for Molecular Pathology v Myriad Genetics case would appear to have overturned three decades of gene patent awards, signaling a clear shift from the Patent and Trademark Office’s past practice.

Nearly 20 years ago, Myriad obtained several pa­tents after discovering the precise location and sequence of the BRCA1 and BRCA2 genes, mutations of which can dramatically in­crease the risk of breast and ovarian cancer. This knowledge enabled Myriad to develop medical tests for detecting muta­tions in these genes to assess a patient’s cancer risk.

The validity of the patents was challenged by a consortium of interested parties. Cancer patients and medical associations were anxious to reduce the cost of such genetic testing, which can run as high as $US 4,000. Scientists raised concerns over restrictions on their ability to use the genes for research, and the impact this had on the free flow of scientific information.

On 13 June 2013, the Supreme Court held that a naturally occurring DNA segment is a product of nature and not patent-eligible merely because it has been isolated. However, synthetic genetic material known as complementary DNA (cDNA) can be patented because it is not naturally occurring. This means that Myriad no longer has the exclusive right to isolate an individual’s BRCA1 and BRCA2 genes, but it can claim exclusive rights to synthetically create BRCA cDNA.

Until the ruling, Myriad held a monopoly on testing for BRCA genes - an issue which was recently brought to the public’s attention with actress Angelina Jolie’s announcement that she had a double mastectomy after testing positive for one of the genes.

The US Patent Act (section 101) permits patents to be issued to in­venters or discoverers of any new and useful composition of matter, but the court held that ‘laws of nature, natural phenomena, and abstract ideas are basic tools of scientific and technological work that lie beyond the domain of patent protection’.

The court explained that without this exception, there would be a danger that the grant of patents would tie up the use of such tools and inhibit future innovation premised upon them. ‘This would be at odds with the very point of patents, which exist to promote creation,’ Thomas J concluded.

Delivering a unanimous judgment for the Supreme Court, Thomas J emphasised that ‘patent protection strikes a delicate balance between creating incen­tives that lead to creation, invention, and discovery, and impeding the flow of information that might permit, indeed spur, invention.’ This standard was used to determine whether Myriad’s pa­tents claim a new and useful composition of matter or claim naturally occurring phenomena.

Myriad’s DNA claim was found to fall within the law of nature exception. While Myriad found an im­portant and useful gene, ‘ground breaking, innovative, or even brilliant discovery’ and extensive effort was not enough to satisfy the ‘new and useful composition of matter’ requirement.

‘Myriad did not create anything’ with isolated DNA, according to Thomas J, as separating the gene from its surrounding genetic material was not an act of invention. However, the cDNA at issue is not a ‘product of nature’, as the lab technician created something new and complementary to the BRCA gene, making it is patent-eligible.

While seen as something of a compromise, this ruling could have profound implications for the biotechnology and drug industry. Myriad’s patents were due to expire over the coming years due to the 20-year limit on patents, but the decision has implications far beyond the scope of the BRCA1 and BRCA2 patents.

Concerns have been raised that it could discourage investment in genetic research by taking away commercial incentive to continue researching into DNA. Some biotech research companies saw it as an about-turn in the international approach to intellectual property rights surrounding genetics.

The US Supreme Court decision forces a change at the US Patent and Trademark Office, which has been awarding gene patents since 1982.

It also contradicts a ruling on gene patenting in Australia's Federal Court in February this year, which decided in favour of Myriad after a similar lawsuit was brought by Cancer Voices Australia. The Federal Court ruled that the two genes, extracted from natural cells obtained from the human body and 'purged of other biological materials,' constituted a 'manner of manufacture' and could therefore be patented’. That decision has been appealed to the Full Court of the Federal Court, with a hearing expected in August.

The Australian Federal Court is not legally bound to follow the US Supreme Court decision, but will no doubt closely examine the US Supreme Court decision in its deliberations.


  • 21/01/2014 1:53 PM
    Genevieve Butler said:

    Myriad held patents on the tests from the late 1990s until the Supreme Court decision in Association for Molecular Pathology v Myriad Genetics. The ruling invalidated five patents held by Myriad, which underpinned Myriad’s BRACAnalysis test, thus breaking Myriad's monopoly on BRCA testing. One of the effects of the case was to open the market for testing to competition. Several other companies immediately said they would offer such tests at a lower cost.

  • 21/01/2014 1:53 PM
    Flabmeister said:

    AS well as a monopoly, do Myriad have a patent for the testing process?

Thank you for your comment. If it does not require moderation, it will appear shortly.
Facebook LinkedIn Twitter Add | Email Print


Flagpost is a blog on current issues of interest to members of the Australian Parliament

Parliamentary Library Logo showing Information Analysis & Advice




refugees asylum immigration Australian foreign policy Parliament elections climate change social security women welfare reform taxation Indigenous Australians Australian Defence Force welfare policy school education higher education private health insurance health financing emissions trading Senate Australian Bureau of Statistics employment people trafficking Asia statistics Middle East illicit drugs gambling health reform federal election 2010 Australian Public Service income management Medicare disability Sport United Nations environment industrial relations constitution transport politics criminal law Afghanistan health forced labour food public service reform aged care aid Australian Sports Anti-Doping Agency World Anti-Doping Agency United States federal budget Carbon Pricing Mechanism dental health international relations governance regulation Fair Work Act voting law enforcement electoral reform OECD Australian Electoral Commission WADA child protection poker machines Australia in the Asian Century steroids National Disability Insurance Scheme detention 43rd Parliament slavery health system leadership domestic violence parliamentary procedure International Women's Day accountability defence capability multiculturalism ASADA Australian Federal Police labour force people smuggling debt New Zealand Australian Crime Commission pharmaceutical benefits scheme political parties coal seam gas Human rights crime China Census election results UK Parliament Papua New Guinea banking corruption pensions children's health Aviation federal election 2013 foreign debt gross debt net debt Senators and Members ALP Newstart Parenting Payment Youth Allowance sea farers United Kingdom energy food labelling Australian economy violence against women vocational education and training military history by-election High Court skilled migration mental health Federal Court terrorist groups science social media Higher Education Loan Program HECS federal state relations youth paid parental leave same sex relationships customs planning doping health risks Gonski Review of Funding for Schooling sex slavery Special Rapporteur Northern Territory Emergency Response social policy ANZUS Rural and regional trade unions Foreign affairs election timetable Indigenous royal commission Productivity firearms public policy Population ADRV terrorism transparency research and development welfare ASIO intelligence community Australian Security Intelligence Organisation carbon tax mining employer employee renewable energy regional unemployment fishing European Union family assistance United Nations Security Council forestry Drugs welfare systems Indonesia children Constitutional reform local government codes of conduct terrorist financing homelessness Parliamentary remuneration money laundering Trafficking in Persons Report social inclusion paternalism environmental law US presidential election nutrition ODA Defence sitting days electoral divisions Southeast Asia administrative law universities TAFE Ireland citizenship asylum seekers early childhood education Canada Financial sector national security fuel disability employment Tasmania integrity standards NATO Australian Secret Intelligence Service sexual abuse World Trade Organization Australia public health housing affordability bulk billing water health policy Governor-General US economy export liquefied natural gas foreign bribery question time speaker superannuation public housing expertise climate Intergovernmental Panel on Climate Change Department of Agriculture Fisheries and Forestry Pacific Islands reserved seats new psychoactive substances synthetic drugs UNODC carbon markets animal health middle class welfare constitutional recognition of local government referendum consumer laws PISA competition policy US politics language education baby bonus Leaders of the Opposition citizen engagement policymaking Australia Greens servitude Trafficking Protocol forced marriage alcohol entitlements ministries Hung Parliament social citizenship maritime Iran regional students school chaplains federal budget 2011-12 salary Medicare Locals primary care Building the Education Revolution marine pollution sustainability prisons police deaths in custody electoral margins electoral pendulum electoral redistribution redistribution NSW redistribution WA redistribution ACT electoral boundaries ASEAN Sustainable Development Goals Double dissolution Senators safety vehicles MYEFO Pathology tertiary education Taiwan Xi Ma meeting family violence government financial advisers financial planners Financial System Inquiry Murray Inquiry China; Economic policy; Southeast Asia; Africa housing Speaker; House of Representatives; Parliament High Court; Indigenous; Indigenous Australians; Native Title ACT Indigenous education Norfolk Island External Territories emissions reduction fund; climate change child care funding refugees immigration asylum procurement Indigenous health e-voting internet voting nsw state elections 44th Parliament 2015 ABS Age Pension Death penalty capital punishment execution Bali nine Bali bombings Trade EU China soft power education Fiji India Disability Support Pension Antarctica Diplomacy by-elections state and territories Bills anti-corruption fraud bribery corporate ownership whistleblower G20 economic reform innovation Members of Parliament Scottish referendum Middle East; national security; terrorism social services Criminal Code Amendment (Misrepresentation of Age to a Minor) Bill 2013 online grooming sexual assault of minors ACT Assembly smoking plain packaging tobacco cigarettes Asia; Japan; international relations Work Health and Safety Migration; asylum seekers; regional processing China; United States; international relations fiscal policy Racial Discrimination Act; social policy; human rights; indigenous Australians Foreign policy Israel Palestine asylum refugees immigration political finance donations foreign aid Economics efficiency human rights; Racial Discrimination Act employment law bullying Animal law; food copyright Australian Law Reform Commission industry peace keeping contracts workplace policies same-sex marriage disorderly conduct retirement Parliament House standing orders prime ministers First speech defence budget submarines workers Somalia GDP world heritage political engagement leave loading Trade; tariffs; safeguards; Anti-dumping public interest disclosure whistleblowing Productivity Commission limitation period cancer gene patents genetic testing suspension of standing and sessional orders live exports infant mortality honorary citizen railways disciplinary tribunals standard of proof World Health Organisation arts international students skilled graduate visas temporary employment visas apologies roads Italy national heritage NHMRC anti-dumping Rent Assistance obesity evidence law sacrament of confession international days DFAT UN General Assembly deregulation Regulation Impact Statements small business Breaker Morant regional engagement social determinants of health abortion Members suspension workplace health and safety marine reserves hearing Victoria astronomy resources sector YMCA youth parliament Korea rebate Australian Greens presidential nomination Racial Discrimination Act political parties preselection solar hot water Financial Action Taskforce Horn of Africa peacekeeping piracy Great Barrier Reef Stronger futures political financing political education Social Inclusion Board early childhood National Quality Framework for Early Childhood Education and Care Murray-Darling Basin sanctions Norway hospitals republic President Barack Obama Presidential visits qantas counselling Korean peninsula Work Choices biosecurity hendra federalism federation preselection therapeutic goods Therapeutic Goods Administration plebiscites computer games pests suicide nuclear COAG Ministerial Councils floods ADHD stimulant medication advertising electricity extradition conscience votes poverty preventative health rural health coastal erosion Parliamentary Budget Office work-life balance

Show all
Show less
Back to top